0.2649

5.66% -0.0107

Vincerx Pharma Inc (VINC)

Overview News Price History Financials Discussions Forecast

Vincerx Pharma Inc stock is traded at $0.2649, with a volume of 142.50K. It is down -5.66% in the last 24 hours and down -31.24% over the past month. Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

Previous Close:

$0.2756

Open:

$0.2756

24h Volume:

142.50K

Relative Volume:

0.28

Market Cap:

$8.49M

Revenue:

Net Income/Loss:

$-48.85M

P/E Ratio:

-0.10

EPS:

-2.65

Net Cash Flow:

$-46.25M

1W Performance:

-13.25%

1M Performance:

-31.24%

6M Performance:

-63.87%

1Y Performance:

-61.42%

1-Day Range:

$0.2551

$0.2756

1-Week Range:

$0.2551

$0.3071

52-Week Range:

$0.2551

$9.3722

Vincerx Pharma Inc Stock (VINC) Company Profile

Name

Vincerx Pharma Inc

Sector

Healthcare (1195)

Industry

Biotechnology (683)

Phone

650-800-6676

Address

260 SHERIDAN AVENUE, PALO ALTO

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

VINC's Discussions on Twitter

Compare VINC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VINC	0.26	8.49M	0	-48.85M	-46.25M	-2.65
VRTX	447.81	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	745.19	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	588.39	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.73	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.22	24.49B	3.30B	-501.07M	1.03B	11.54

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-14-22	Initiated	H.C. Wainwright	Buy
Dec-23-21	Initiated	Cantor Fitzgerald	Overweight
Nov-01-21	Initiated	SVB Leerink	Outperform
Sep-13-21	Initiated	Laidlaw	Buy
Aug-25-21	Initiated	B. Riley Securities	Buy

Vincerx Pharma Inc Stock (VINC) Latest News

Nov 16, 2024

Vincerx Pharma Inc reports results for the quarter ended September 30Earnings Summary - XM

Nov 12, 2024

Vincerx Pharma Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024

Vincerx Pharma Reports Complete Responses in VIP943 Trial, Narrows Q3 Loss to $0.17/Share | VINC Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

VINC stock touches 52-week low at $0.32 amid market challenges - Investing.com Canada

Nov 08, 2024

Nov 05, 2024

SEC Form PRE 14A filed by Vincerx Pharma Inc. - Quantisnow

Nov 05, 2024

Oct 16, 2024

VINC Stock on the Rise: A Promising Investment - The InvestChronicle

Oct 16, 2024

Oct 14, 2024

Should investors be concerned about Vincerx Pharma Inc (VINC)? - US Post News

Oct 14, 2024

Financial Health Check: Examining Vincerx Pharma Inc (VINC)’s Key Ratios - The Dwinnex

Oct 14, 2024

Oct 10, 2024

What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance

Oct 10, 2024

Check Out Vincerx Pharma Inc (VINC)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 10, 2024

Oct 09, 2024

Taking a Closer Look At Vincerx Pharma Inc (VINC) Following Its Recent Trade - Knox Daily

Oct 09, 2024

Oct 08, 2024

VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges By Investing.com - Investing.com South Africa

Oct 08, 2024

VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com

Oct 08, 2024

Wall Street Analyst Initiated Vincerx Pharma Inc [VINC]. What else is Wall St. saying - The DBT News

Oct 08, 2024